IONQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IONQ is not a clear buy right now for a Beginner long-term investor with $50,000-$100,000 who does not want to wait for a better entry. The stock has strong growth momentum and positive event-driven catalysts, but the current setup is mixed: price is near resistance, technical momentum is only moderate, options sentiment is balanced, and the company is still deeply unprofitable. My direct view is hold, not buy, at the current pre-market price of 44.91.
IONQ is trading pre-market at 44.91, slightly below the pivot at 44.582 and well below resistance at 48.16. MACD histogram is positive at 0.315 but contracting, which means upside momentum is weakening rather than accelerating. RSI_6 at 63.2 is neutral-to-bullish, not oversold, so this is not a deep pullback entry. Moving averages are converging, suggesting the trend is consolidating rather than breaking out decisively. Near-term trend bias is modestly positive, but the stock is not showing a strong technical buy signal right now.
["IonQ secured a DARPA contract, which strengthens its government and defense opportunities.", "Revenue surged 429% YoY in Q4 to $61.9M, showing very strong top-line growth.", "Full-year 2025 revenue reached $130M, up 202% YoY.", "Analyst coverage remains constructive overall, with Northland initiating Outperform and a $55 target.", "Congress trading data shows 1 purchase and 0 sales in the last 90 days, a mildly bullish signal.", "News flow highlights quantum computing as a large long-term market opportunity."]
["IonQ remains highly unprofitable, with net income sharply negative and gross margin still deeply negative.", "Analyst targets have been cut by several firms, showing some caution on valuation and commercialization timing.", "Wolfpack Research published a bearish report questioning Pentagon contract funding and bookings quality.", "The stock is close to resistance, which limits immediate upside for an impatient buyer.", "Options data is balanced rather than strongly bullish, so sentiment is not one-sided.", "The business is still in an early commercialization phase, making long-term execution highly dependent."]
In Q4 2025, IonQ posted revenue of $61.89M, up 428.52% YoY, which is excellent growth. However, profitability remains very weak: net income was -$753.67M, EPS was -2.18, and gross margin was -36.11%. The latest quarter shows strong demand and scaling revenue, but losses are still widening at an unacceptable level for a conservative long-term beginner investor.
Wall Street is mixed but generally constructive on the long-term quantum story. Recent positives include Northland initiating Outperform with a $55 target, Mizuho keeping Outperform but cutting target to $61, Benchmark keeping Buy with a $65 target, and Jefferies keeping Buy with a $90 target. The bearish side is more cautious: JPMorgan is Neutral at $42, Morgan Stanley is Equal Weight at $35, and DA Davidson is Neutral at $35. Overall, pros see major upside from quantum computing adoption, while cons focus on commercialization risk, valuation compression, competition, and execution uncertainty.
